A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Conditions : LA HNSCC Interventions : Drug: Pucotenlimab; Drug: Becotatug vedotin; Radiation: Radiotherapy Sponsors : Jiangsu Cancer Institute & Hospital Not yet recruiting